In this study, the anticancer effect of vulpinic acid on MCF-7 (ER + , PR + and HER2-) breast cancer cells and MCF-12A noncancerous breast epithelial cells was determined for the first time using the xCELLigence real-time cell analysis (RTCA) system. The gene discussed is ERBB2; the disease is breast cancer.